Initial Public Offerings
- IPO News (beta)
- Recent Filings
- IPO Calendar
- Recent Pricings
- IPO Withdrawals
- Quiet Period
- Deal Flow
- Lockup Expirations
- Best-Worst Performers
- Industry Analysis
- Underwriter Performance
- Quarterly Reviews
Secondary Offerings
- Recent Filings
- Calendar
- Recent Pricings
- Quiet Period
- Deal Flow
- Best-Worst Performers
- Industry Analysis
- Underwriter Performance
- Quarterly Reviews
Tools
Recent Filings - Secondary Offerings
| Date | Company | Location | Amount |
|---|---|---|---|
| 2022-07-01 | ATAI Life Sciences B.V. | Berlin, GERMANY | $300.0 mil. |
| A clinical-stage biopharmaceutical company | |||
| 2022-07-01 | Elevation Oncology, Inc. | New York, NY | $250.0 mil. |
| A precision oncology company | |||
| 2022-07-01 | Alpha Teknova, Inc. | Hollister, CA | $225.0 mil. |
| A leading provider of critical reagents that enable the production of biopharmaceutical products | |||
| 2022-07-01 | Acumen Pharmaceuticals, Inc. | Charlottesville, VA | $200.0 mil. |
| A clinical-stage biopharmaceutical company | |||
| 2022-07-01 | Century Therapeutics, Inc. | Philadelphia, PA | $500.0 mil. |
| An innovative biotechnology company | |||
| 2022-07-01 | Miromatrix Medical Inc. | Eden Prairie, MN | $200.0 mil. |
| A life sciences company | |||
| 2022-07-01 | Verve Therapeutics, Inc. | Cambridge, MA | $400.0 mil. |
| A genetic medicines company | |||
| 2022-07-01 | Evelo Biosciences, Inc. | Cambridge, MA | $75.0 mil. |
| Discovers and develops potential therapies designed to act on the gut-body network. | |||
| 2022-07-01 | Willamette Valley Vineyards, Inc. | Turner, OR | $20.0 mil. |
| One of the leading producers of Pinot noir in Oregon | |||
| 2022-07-01 | Acurx Pharmaceuticals, LLC | Staten Island, NY | $50.0 mil. |
| A clinical stage biopharmaceutical company | |||
| 2022-07-01 | iSpecimen Inc. | Lexington, MA | $100.0 mil. |
| A biotechnology company | |||
| 2022-07-01 | POINT Biopharma Global Inc. | Indianapolis, IN | $400.0 mil. |
| Develops next-generation radiopharmaceuticals for the treatment of cancer. | |||
| 2022-07-01 | Femasys Inc. | Suwanee, GA | $150.0 mil. |
| A biomedical company | |||
| 2022-07-01 | Galmed Pharmaceuticals Ltd. | Tel Aviv, ISRAEL | $8.70 mil. |
| A clinical-stage biopharmaceutical company | |||
| 2022-07-01 | ClearSign Technologies Corp | Seattle, WA | $50.0 mil. |
| Designs and develops technologies | |||
| 2022-07-01 | Centessa Pharmaceuticals Ltd | Cambridge, UNITED KINGDOM | $350.0 mil. |
| A next-generation biopharmaceutical company | |||
| 2022-07-01 | ChargePoint Holdings, Inc. | Campbell, CA | $1,000.0 mil. |
| A leading EV charging technology solutions provider | |||
| 2022-07-01 | Monte Rosa Therapeutics, Inc. | Boston, MA | $300.0 mil. |
| A biopharmaceutical company | |||
| 2022-06-30 | Seres Therapeutics, Inc. | Cambridge, MA | $100.0 mil. |
| A microbiome therapeutics platform company | |||
| 2022-06-30 | Hudson Global, Inc | Old Greenwich, CT | $100.0 mil. |
| A leading total talent solutions provider | |||
| More >> | |||